2019 Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit (PCR Fluorescence Probe Method) is used for the in vitro qualitative detection of 2019 novel coronavirus (2019-nCoV) RNA in upper respiratory tract specimens (nasopharyngeal and oropharyngeal extracts) by real time PCR systems. It is considered as an aid in the diagnosis of the 2019-nCoV infection.
Ref. - Type of Reagent - Presentation 24rxns
1 - PCR Reaction Buffer 1 - 1 vial, 384μL
2 - ORF1ab / N Gene Primer and Probe Mixture - 1 vial, 48μL
3 - Enzyme System 1 - 1 vial, 48μL
4 - Negative Control 1 - 1 vial, 400μL
5 - ORF1ab / N Positive Control - 1 vial, 400μL